Best treatments for pseudomembranous enterocolitis
17 products may treat pseudomembranous enterocolitis, spanning FDA drug classes such as macrolide antibacterial, glycopeptide antibacterial, bile acid sequestrant. The current highest-rated option is dificid. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.
Quick answer: Of the 17 drugs we list for pseudomembranous enterocolitis, all are available as lower-cost generics, spanning classes such as macrolide antibacterial, glycopeptide antibacterial, bile acid sequestrant. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for pseudomembranous enterocolitis — so confirm the right choice with your prescriber.
Understanding pseudomembranous enterocolitis
"Enterocolitis, Pseudomembranous" is the MeSH heading for what clinicians call pseudomembranous colitis. MedlinePlus (NLM) defines it as "swelling or inflammation of the large intestine (colon) due to an overgrowth of Clostridioides difficile bacteria," typically after antibiotics have thinned the gut flora that keep C. diff in check; the bacteria then "give off a strong toxin that causes inflammation and bleeding in the lining of the colon." The name describes what a colonoscope sees — StatPearls (NCBI Bookshelf) reports raised yellowish, sometimes hemorrhagic plaques up to 2 cm across, scattered among healthy-looking mucosa. StatPearls also lists other causes of the same picture (ischemic colitis, inflammatory bowel disease, CMV colitis, vasculitis, Behçet's disease, chemotherapy), so a pseudomembrane is a finding, not automatically a C. diff diagnosis. Two things people get wrong. First, testing: CDC clinical guidance says labs should test only unformed stool, and that laxatives should be discontinued with a 48-hour wait before testing. Second, and counterintuitively, CDC says that once a patient tests positive, you do not repeat testing to prove cure — tests can stay positive for six weeks or longer. Scale, per StatPearls: almost 500,000 episodes and 29,000 deaths a year in the US, roughly 20% relapse after treatment, and 3–8% progress to fulminant disease including toxic megacolon. This is general information, not medical advice — discuss your own case with a clinician.
First-line treatment
The 2021 SHEA/IDSA focused update for managing Clostridioides difficile infection in adults states: "For patients with an initial CDI episode, we suggest using fidaxomicin rather than a standard course of vancomycin (conditional recommendation, moderate certainty of evidence)," adding that "Vancomycin remains an acceptable alternative." For recurrence, the panel likewise suggests fidaxomicin (standard or extended-pulsed) over a standard vancomycin course, with vancomycin in a tapered and pulsed regimen an acceptable alternative for a first recurrence, and suggests bezlotoxumab as a co-intervention alongside standard-of-care antibiotics when an episode has recurred within the last 6 months. MedlinePlus (NLM) adds that "the antibiotic or other medicine causing the condition should be stopped." Regimens and dosing are a prescriber's decision.
Top-rated picks for pseudomembranous enterocolitis: 1. Dificid · 2. Tyzavan · 3. Firvanq Kit
| # | Drug | Rating | Type | Form | Class | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|---|
| 1 | 72/100 | Prescription | Suspension | Macrolide Antibacterial | Generic | $4760 | View → | |
| 2 | 72/100 | Prescription | Injectable | Glycopeptide Antibacterial | Generic | $1 | View → | |
| 3 | 70/100 | Prescription | Kit | Glycopeptide Antibacterial | Generic | $1 | View → | |
| 4 | 66/100 | Prescription | Suspension | Bile Acid Sequestrant | Generic | $20 | View → | |
| 5 | 64/100 | Prescription | Suspension | Bile Acid Sequestrant | Generic | $20 | View → | |
| 6 | 64/100 | Prescription | Suspension | Bile Acid Sequestrant | Generic | $20 | View → | |
| 7 | 62/100 | Prescription | Suspension | Bile Acid Sequestrant | Generic | $8 | View → | |
| 8 | 60/100 | Prescription | Capsule | Glycopeptide Antibacterial | Generic | $1 | View → | |
| 9 | 56/100 | Prescription | Topical | Nitroimidazole Antimicrobial | Generic | $0 | View → | |
| 10 | Not yet rated | Prescription | Injectable | Nitroimidazole Antimicrobial | Generic | $0 | View → |
Narrow by drug class
Explore the class hubs: nitroimidazole antimicrobial · bile acid sequestrant · glycopeptide antibacterial
Full ranking · 17 treatments
dificid
PrescriptionFDA-sourced
Dificid (Fidaxomicin) is a macrolide antibacterial used to treat Pseudomembranous Enterocolitis.
Pharmacy pays
~$4759.74 /30
tyzavan
Boxed warningPrescriptionFDA-sourced
Tyzavan (Vancomycin Hydrochloride) is a glycopeptide antibacterial used to treat Diarrhea, Bacterial Endocarditis, Pseudomembranous Enterocolitis, Pneumococcal Meningitis.
Pharmacy pays
From ~$0.46· 6 formsfirvanq kit
PrescriptionFDA-sourced
Firvanq Kit (Vancomycin Hydrochloride) is a glycopeptide antibacterial used to treat Diarrhea, Bacterial Endocarditis, Pseudomembranous Enterocolitis, Pneumococcal Meningitis.
Pharmacy pays
From ~$0.46· 6 formscolestipol hydrochloride
PrescriptionFDA-sourced
Colestipol Hydrochloride is a bile acid sequestrant used to treat Coronary Artery Disease, Diarrhea, Pseudomembranous Enterocolitis, Hypercholesterolemia.
Pharmacy pays
~$20.09 /30
Save up to 58% in classcolestid
PrescriptionFDA-sourced
Colestid (Colestipol Hydrochloride) is a bile acid sequestrant used to treat Coronary Artery Disease, Diarrhea, Pseudomembranous Enterocolitis, Hypercholesterolemia.
Pharmacy pays
~$20.09 /30
Save up to 58% in classflavored colestid
PrescriptionFDA-sourced
Flavored Colestid (Colestipol Hydrochloride) is a bile acid sequestrant used to treat Coronary Artery Disease, Diarrhea, Pseudomembranous Enterocolitis, Hypercholesterolemia.
Pharmacy pays
~$20.09 /30
Save up to 58% in class- Colesevelam Hydrochloride
- Vancomycin Hydrochloride
- Vandazole
- Flagyl I.V. Rtu in Plastic Container
- Likmez
- Metrocream
- Metrogel
- Metrolotion
- Metronidazole
- Noritate
- Nuvessa
Frequently asked
- What treats pseudomembranous enterocolitis?
- Our catalog lists 17 products that may treat pseudomembranous enterocolitis, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is dificid.
- What is the best-rated treatment for pseudomembranous enterocolitis?
- By our independent recall-safety rating — not an efficacy measure — dificid ranks highest among the products we list for pseudomembranous enterocolitis. Always consult a professional.
- How are these treatments ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
- What types of drugs treat pseudomembranous enterocolitis?
- Treatments for pseudomembranous enterocolitis span FDA drug classes including macrolide antibacterial, glycopeptide antibacterial, bile acid sequestrant, nitroimidazole antimicrobial. Compare every option side by side, ranked by independent rating, above.
Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.
Sources
The clinical overview above is written from these authoritative public-health and medical-society sources, independently reviewed against each.
- Pseudomembranous colitis — MedlinePlus Medical Encyclopedia (NLM) ↗
- Pseudomembranous Colitis — StatPearls, NCBI Bookshelf ↗
- Clinical Guidance for C. diff Infection Prevention in Acute Care Facilities — CDC ↗
- SHEA/IDSA 2021 Clinical Practice Guideline Update for the Management of Clostridioides difficile Infection in Adults ↗